BeiGene Announces European Medicines Agency Acceptance of its Marketing Authorization Application for BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Waldenström’s Macroglobulinemia

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs